Valneva SE

VALNEVA - Declaration of shares and voting rights: Status on December 31, 2022 (corrected data) and January 4, 2023

19 1 2023 11:00:00 提供 Nasdaq GlobeNewswire

VALNEVA - Declaration of shares and voting rights: December 31, 2022

05 1 2023 11:00:00 提供 Nasdaq GlobeNewswire

Valneva Reports Further Heterologous Booster Data for its inactivated COVID-19 vaccine

30 12 2022 11:30:00 提供 Nasdaq GlobeNewswire

Valneva Completes BLA Submission to U.S. FDA for its Single-Shot Chikungunya Vaccine Candidate

23 12 2022 00:00:00 提供 Nasdaq GlobeNewswire

Valneva to Conduct Investor Meetings during the J.P. Morgan Healthcare Conference and Oddo BHF Forum

21 12 2022 10:45:00 提供 Nasdaq GlobeNewswire

Valneva Hosts Investor Day in New York City

06 12 2022 00:00:00 提供 Nasdaq GlobeNewswire

VALNEVA - Declaration of shares and voting rights: November 30, 2022

05 12 2022 11:00:00 提供 Nasdaq GlobeNewswire

Valneva Reports Positive 12-Month Antibody Persistence Data for Single-Shot Chikungunya Vaccine Candidate

05 12 2022 00:00:00 提供 Nasdaq GlobeNewswire

Valneva to Host Investor Day in New York City

29 11 2022 11:00:00 提供 Nasdaq GlobeNewswire

Valneva Appoints Dipal Patel as Chief Commercial Officer

17 11 2022 00:00:00 提供 Nasdaq GlobeNewswire

Valneva Reports Nine-Month 2022 Results and Provides Corporate Updates

10 11 2022 00:00:00 提供 Nasdaq GlobeNewswire

Valneva to Present and Hold Investor Meetings at the Jefferies London Healthcare Conference

07 11 2022 10:45:00 提供 Nasdaq GlobeNewswire

VALNEVA - Declaration of shares and voting rights: October 31, 2022

04 11 2022 12:00:00 提供 Nasdaq GlobeNewswire

Valneva to Present on its Single-Shot Chikungunya Vaccine Candidate at Leading Scientific Conferences

10 10 2022 00:00:00 提供 Nasdaq GlobeNewswire

VALNEVA - Declaration of shares and voting rights: Interim status at October 4, 2022 (and information at September 30, 2022)

07 10 2022 11:00:00 提供 Nasdaq GlobeNewswire

Valneva Announces Closing of Upsized €102.9 Million Global Offering

04 10 2022 15:00:00 提供 Nasdaq GlobeNewswire

Valneva Announces Pricing of €102.9 Million Global Offering of American Depositary Shares and Ordinary Shares

30 9 2022 00:11:36 提供 Nasdaq GlobeNewswire

Valneva Announces Launch of Approximately $40 Million in a Proposed Global Offering of American Depositary Shares and Ordinary Shares

28 9 2022 16:43:47 提供 Nasdaq GlobeNewswire

Valneva Provides Further Update on its COVID-19 Activities

26 9 2022 00:00:00 提供 Nasdaq GlobeNewswire

Valneva and IDT Biologika Agree on Termination of their COVID-19 Collaboration

16 9 2022 15:30:00 提供 Nasdaq GlobeNewswire